Gregory A. Broderick, M.D.

Gregory A. Broderick, M.D., serves as a Consultant in the Department of Urology at Mayo Clinic in Jacksonville, Florida. He is a Professor of Urology, Mayo Clinic Alix School of Medicine. Dr. Broderick has been a member of the Mayo Clinic Florida staff since 1998, and has served on Continuous Professional Development Committee, Graduate Medical Education, Personnel Committee, Academic Appointments and Promotions Committees and as Program Director to the Urology Residency (2000-2023). His practice is focused on Men's Health: Erectile Dysfunction, Peyronie's disease, Urethral Stricture Disease, Male Stress Incontinence, and BPH.

Dr. Broderick established the Urologic Residency in 2000. He has served as Vice-Chair to the Graduate Education Committee Mayo Clinic Florida. In recognition of his dedication to graduate education, he was honored by Jacksonville Business Magazine as an Innovator in Education and by Mayo Clinic Florida as Distinguished Educator of the Year, both in 2016. The Distinguished Educator Award is given to faculty demonstrating long-term excellence, and leadership. In 2023 he was elected to the Urology Residency Review Committee of the Accreditation Council for Graduate Medical Education (ACGME).

Dr. Broderick is an active member of the Florida Urologic Society, Southeastern Section AUA and the American Urological Association. He is the 2023 Florida Urologic Society Lifetime Achievement Award recipient. A longstanding member and Fellow of the Sexual Medicine Society of North America, he served as SMSNA President (2005). He is currently an Executive Committee member to SMSNA and the SMSNA Foundation. He has served as a co-author of AUA Clinical Guidelines for Priapism, Premature Ejaculation, and Erectile Dysfunction. He has served as Section Editor for AUA Core Curriculum (Priapism). He has served on the Sexual Health Function Council to AUA Foundation and Survivorship Committee to the National Comprehensive Cancer Network (NCCN, 2018-2021).

He has served as an Oral Examiner for Urology Boards since 2020. Dr. Broderick was elected Trustee of the American Board of Urology (ABU). His six-year term began on February 22, 2023. Dr. Broderick was nominated to the ABU by the Society of Academic Urologists. Founded in 1935, the ABU acts for the benefit of the public by establishing and maintaining standards of certification for urologists, working with certified urologists to achieve lifelong learning to insure the delivery of high quality, safe and ethical urologic care. Six urologic societies nominate to the ABU and sponsor its activities, including the American Urological Association, the American Association of Genitourinary Surgeons, the American Association of Clinical Urologists, the American College of Surgeons, the Society of Academic Urologists, and the Societies for Pediatric Urology.

As of 2022, Dr. Broderick has contributed 149 peer reviewed publications and 23 chapters in the field of Urology. His Scopus h-index is 43, his ORCID is 0000-0003-2949-5425. (https://www.scopus.com/authid/detail.uri?authorId=57190959702)